Blood 2019 Jul 25
How I treat polycythemia vera.
Related Questions
No evidence of palpable splenomegaly, normal hematocrit and platelet count
New answer by at Johns Hopkins University (June 28, 2022)
First, let's abandon the phase "BCR/ABL-negative MPN". This is an oxymoron because BCR/ABL can be expressed in a JAK2 driver mutation-positive MPN. In fact, both BCR/ABL and J...
Do you think it will become first-line therapy? Is potential iron overload a concern with long-term use?
Bankar et al. VERIFY: A randomized controlle...
New answer by at Johns Hopkins University (July 15, 2025)
Rusfertide, an injectable hepcidin mimetic (1), is another new arrow in the quiver of 21st-century therapies for controlling erythropoiesis without phlebotomy in polycythemia ...